RTOG 1205. Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Mitchel Fromm, MD
McDowell Cancer Research at 330-344-6348
CTSU A221101. A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) to Reduce Cancer-Related Fatigue in Patients with High Grade Glioma
Esther Rehmus, MD
Akron General Medical Center 1 Akron General Avenue (Formerly 400 Wabash Avenue) Akron, OH 44307 330-344-6000 1-800-221-4601 © 2014 Akron General Health System
This site complies with the HONcode standard for trustworthy health information: verify here.